SSI Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

SSI Investment Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298K	Sell	1,567 -34,514	-96%	-$5.93M	0.02%	227
2026 Q1	$6.09M	Sell	36,081 -23	-0.1%	-$3.93K	0.42%	83
2025 Q4	$6.09M	Buy	+36,104	New	+$5.86M	0.41%	80
2023 Q1	–	Sell	-21,577	Closed	-$2.83M	–	269
2022 Q4	$2.83M	Hold	21,577	–	–	0.18%	130
2022 Q3	$2.52M	Buy	+21,577	New	+$2.68M	0.17%	143
2017 Q1	–	Sell	-24,789	Closed	-$2.19M	–	307
2016 Q4	$2.19M	Hold	24,789	–	–	0.2%	163
2016 Q3	$2.39M	Buy	24,789 +441	+2%	+$42K	0.21%	156
2016 Q2	$2.09M	Buy	+24,348	New	+$2.18M	0.2%	154

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

SSI Investment Management's IBB Position: Q2 2026 in Review

SSI Investment Management reduced its iShares Biotechnology ETF (IBB) stake by 96% in Q2 2026, selling an estimated $5.93M and leaving 1,567 shares worth $298K. The position accounts for 0.02% of the portfolio, ranked #227.

SSI Investment Management first reported a position in IBB in Q2 2016 and has held it in 8 quarters since. The position peaked at $6.09M in Q4 2025. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

SSI Investment Management held 1,567 shares of iShares Biotechnology ETF worth $298K as of Q2 2026.
SSI Investment Management sold 34,514 iShares Biotechnology ETF shares in Q2 2026, an estimated $5.93M.
iShares Biotechnology ETF made up 0.02% of SSI Investment Management's portfolio in Q2 2026, its #227 holding.
SSI Investment Management first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 8 quarters since.
SSI Investment Management's iShares Biotechnology ETF position peaked at $6.09M in Q4 2025.
957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on SSI Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.